Annual Meeting

Papers and Posters

Accepted papers:

  • Opioid Use Disorder and Homelessness in the Veterans Health Administration: The Challenge of Multi-morbidity by Theddeus Iheanacho
  • Characteristics associated with long-acting naltrexone treatment persistence by Grace Chang
  • Efficacy of Buprenorphine (BPN) Depot Injections vs. Sublingual BPN for Opioid Use Disorder: A Phase 3 RCT by Michelle Lofwall
  • Digital Natives in a Tele-Medical World: Evaluation of a Pilot Educational Elective in Tele-Addiction and Role of Tele-Medical Education in Addiction Fellowship by Kathleen Broad
  • Alcohol craving measured by the Penn Alcohol Craving Scale (PACS) predicts relapse risk after residential substance use disorder treatment by Matthew Stohs
  • Unique and shared effects of alcohol, marijuana, and tobacco on electrophysiological signatures of reward and punishment processing, impulsivity, and affect in adolescent daily cigarette smokers by Christopher Hammond
  • Why rimonabant (Acomplia)-induced dysphoria SHOULD have been expected by Eliot Gardner
  • Smokeless Tobacco Use and Low Birth Weight Children Among Women in a Rural Setting of Chennai, India by Delfin Lovelina Francisv
  • Medical-Surgical Hospitalizations by Veterans with Psychiatric and Substance Use Disorders by David Moore
  • The Impact of Treating Psychiatric Comorbidities On The Ability To Quit Smoking by Maher Karam-Hage
  • Neurocognitive Testing to Assess Efficacy of Substance Abuse Treatment in Residential Facilities by Robert Lynn Horne

Accepted posters:

  • Medical Residents’ Attitudes Towards Patients with Substance Use Disorders by Jonathan Avery, presented by Kristopher Kast
  • Mortality in a Supportive Housing Program is Associated with Alcohol Use, Liver Disease, and HIV by David Moore
  • Neurocognitive Testing to Determine ADHD in Residential Alcohol and Substance Abuse Patients by Robert Lynn Horne
  • Engaging Adolescents: Animal-Assisted Therapy for Adolescents with Psychiatric and Substance Use Disorders by Kate Trujillo
  • Psychotherapy and three-year retention in buprenorphine treatment for opioid use disorder by Ajay Manhapra
  • Buprenorphine Treatment in Kentucky during 2009–2016 and the Effects of House Bill 1 by Anjali Dhanda
  • Baclofen for AUD: a review of clinical evidence and practices by Corina Freitas
  • Transdisciplinary Training for those working with Co-Occurring Disorders by Amelia Roeschlein
  • Assessment of Psychiatrists’ Practice Patterns for the Recognition and Management of Opioid Use Disorder by Thomas Finnegan
  • Use of Smartphone Apps as Complementary Treatment for Patients with Substance Use Disorders by Jessica Allen
  • Outpatient Transition to Extended-release Naltrexone in Patients With Opioid-use Disorder by Adam Bisaga
  • Transition to Extended-release Naltrexone: Heroin Versus Prescription Opioid Users by Paolo Mannelli
  • Theoretical Domains Framework Survey Evaluation Identify Domains of Prescribers’ Behaviors with Benzodiazepines by Melissa Christopher
  • The Effectiveness of Gabapentin in Reducing Cravings and Withdrawal in Alcohol Dependence: A Meta-Analytic Review by Saeed Ahmed
  • Substance use disorders and their impact on the psychiatric & justice system by Kristen Schmidt
  • Extended-release Naltrexone Decreases Opioid Craving Across the 4-Week Dosing Interval by Evgeny Krupitsky
  • Treatment retention and outcomes with the Adolescent Community Reinforcement Approach in emerging adults with opioid use by Justine Welsh
  • Buprenorphine Retention in Outpatient Mental Health: Comparing primary care and mental health outcomes in a large urban safety net hospital by Brad Stankiewicz
  • Cardiovascular Disease as a Predictor of Psychological and Medical Problems in Veterans by Alexandria Cantarero
  • Benzodiazepine Usage in an Outpatient Methadone Clinic Setting by Bellelizabeth Foster
  • The Effects of Repeated Delta-9-Tetrahydrocannabinol Administration to Adolescent Rhesus Monkeys on Working Memory by David Mathai
  • Interaction Between Pre-Treatment Stimulant Use and Psychiatric Diagnoses on Treatment Outcomes in Adults with Co-Occurring Disorders by Michael McDonell
  • QTc Interaction of Lofexidine with Opioid Maintenance Medications: Methadone by Charles Gorodetzky
  • QTc Interaction of Lofexidine with Opioid Maintenance Medications: Buprenorphine by Charles Gorodetzky
  • The Mannequin Challenge: Psychiatric Simulation using a Novel Case Involving Alcohol Withdrawal by Ish Bhalla
  • Kratom (Mitragynine) Use on the Rise: A Case Series from a VA Substance Treatment and Recovery Program by Karen Hartwell
  • Bipolar disorder and Buprenorphine by Shawn Cassady
  • Rate of Screening for Substance Use Disorders in a Prenatal Clinic by Katherine Callaghan
  • Intrauterine Exposure to Methadone or Buprenorphine: Incidence and Severity of Neonatal Abstinence Syndrome by Raghavendra Parige
  • Health care utilization and costs associated with pharmacological vs. non-pharmacological therapy for opioid dependence by Margaret Duncan
  • Ambulatory Detoxification Program for Alcohol Withdrawal Using Remote Monitoring Devices by Alan Gordon
  • Examining the Effects of Varenicline on Cognition as a Function of Smoking Status in Patients with Schizophrenia and Controls by Karolina Kozak
  • Open Label Tolerability Study of Lofexidine HCl by Marc Fishman
  • Sex differences in the clinical psychiatric presentations of natural and synthetic cannabinoids users by Anahita Bassirnia
  • OSCEs Identify SBIRT Training Needs for Medical Students by Jennifer Smith
  • Substance Abuse and the Intentional Ingestion of Foreign Objects: Potential for Intervention by Anna Lisa Derrien
  • The Incorporation of SBIRT Training in Dental School Education by Kelly Granger
  • Attitudes and Knowledge About Fentanyl in Patients with Opioid Use Disorder by Claudia Rodriguez
  • Substance abuse in the elderly inpatient psychiatric population by Ori-Michael Benhamou
  • Stimulant use among a sample of college and medical students in the southern United States by Juvraj Padda
  • Naloxone Overdose Kits: Assessment of Knowledge, Attitudes, and Barriers to Implementation Amongst Psychiatric Residents by Jerry Joseph
  • The socio-structural implications of the ever changing landscape of bath salts by Deepak Alapati
  • Initial Appointments with Physicians: Missed Opportunities to Address Smoking by James Walker
  • The Many Domains of Self-Efficacy and Their Individual Roles in the Treatment of Alcohol Use Disorder by Marquette Rose
  • Association between binge drinking and the reason of drinking – A cross sectional study of college student of 35 colleges in Japan by Kyoko Kawaida
  • Electronic Cigarettes: Review of Safety and Use by Sidarth Wakhlu
  • Opioid Death Trends (Accidental vs. Intentional) North Carolina vs. the United States of America by Jessica Allen
  • New Opioids On The Horizon by Allen Dsouza
  • Predictors of Retention in Treatment for Opioid Use Disorder Following Administration of RBP-6000 vs. Placebo by Celine Laffont
  • Stimulant Misuse in adult ADHD with comorbid Substance Use Disorder (or Stimulant Use Disorder): Missing “ Due Diligence”: A Case Report and Literature Review by Nuria Thusius
  • Drug-Related Mortality in Camden County and Gloucester County, N.J. Between 2013-2015 by Jessica Healey
  • Integrated Treatment for Persistent Depression and Alcohol Use Disorder: An Innovative Pilot Study by Surbhi Khanna
  • Factors affecting Long-term Retention on Opioid Agonist Maintenance Treatment in a Community Drug Treatment Clinic: A Retrospective Cohort Study from India by Ravindra Rao
  • Determining Drinking Criteria for Transgender Veterans Entering Randomized Controlled Trials of Topiramate Treatment by Edith Harris
  • Fatal Overdose Following Insufflation of an Unknown Substance by Robert Rymowicz
  • Buprenorphine/Naloxone Therapy in an Inner City Methadone Maintenance Treatment Program by Jonathan Samuels
  • Adderall Induced Delusional Parasitosis: A Case Report and Literature Review by Martha Ignaszewski
  • ‘Gateway drugs’ and their relatedness to method of opioid administration by Ruosi Liu
  • Health care utilization and costs associated with opioid dependence treatments by Margaret Duncan
  • What to Expect When They’re Withdrawing: support for integrated care models in pregnancy complicated by opioid use by Marguerite Maguire
  • Cannabis use and cocaine use are independent predictors of phencyclidine (PCP) use in DC Urban population with lower socioeconomic status by Walid Aziz
  • Effects of Synthetic Cannabinoid in patients with Schizophrenia. A case report and literature Review by Victor Nettey
  • Prevalence of Behavioral and Emotional Problems in School going Adolescents in India by Anshu Gupta
  • Characteristics of Sports Psychiatry Patients with Opioid Use Disorder by Claire Twark
  • Psilocybin-assisted treatment for alcohol use disorder: a clinical perspective by Sean Amegadzie
  • Effects of Extended Cannabis Abstinence on Symptoms of Anxiety in Schizophrenia by Aliya Lucatch
  • Amphetamines and Sex: Erectile Dysfunction and Reduced Sexual Satisfaction OR Positive Sexual Function? by Nuria Thusius
  • Opiate induced catatonia in a middle aged woman by Fabrizzio Delgado
  • Association between alcohol-related injuries and aldehyde dehydrogenase 2 deficiency in college students: A cross-sectional study in Japan by Hisashi Yoshimoto
  • Treatment of the Chemically Dependent Professional by Christopher Rodgman
  • Hand to God: Cannabis Psychosis and Withdrawal by Nora Carson
  • Cost implications of illicit drug use in a psychiatric emergency program, a retrospective analysis by Corina Freitas
  • Effects of Extended-release Naltrexone Extend Beyond Exogenous Opioid Blockade: Clinical Trial Observations by Edward Nunes